英文别名 |
GSK'481;GSK481;CS-2186;GSK481 - GSK'481;3-Isoxazolecarboxamide, 5-(phenylmethyl)-N-[(3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-;(S)-5-Benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)isoxazole-3-carboxamide;GSK481,inhibit,Inhibitor,RIPK,GSK-481,RIP kinase,GSK 481,Receptor-interacting protein kinases;CCG-268375;F85404;EX-A2322;BDBM50159507;XPC84958;Q27456224;1622849-58-4;GSK481?;HY-100131;GSK-481;MS-26140;s8169;AC-33608;CS-5709;SCHEMBL15964718;65U;5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide;5-Benzyl-N-[(3s)-5-Methyl-4-Oxo-2,3,4,5-Tetrahydro-1,5-Benzoxazepin-3-Yl]-1,2-Oxazole-3-Carboxamide;DA-53753;AKOS030526615;CHEMBL3785703;Z2723063796 |